Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Journal of Clinical Pathology
|
August 16, 2023
Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma
Qiqi Ye, Hui Chen, Cody Han, et al.
Molecular Cancer Research : MCR
|
September 15, 2007
Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status
Martín C Abba, Hongxia Sun, Kathleen A Hawkins, et al.
Molecular Oncology
|
March 8, 2014
Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue
Bilge Aktas, Hongxia Sun, Hui Yao, et al.
Virchows Archiv : an International Journal of Pathology
|
May 7, 2025
Upregulation of MMP9 expression in postradiation angiosarcoma of the breast: a possible predictive risk factor
Qingqing Ding, Phyu P Aung, Hongxia Sun, et al.
Biochimie
|
March 26, 2009
Stabilizing parallel G-quadruplex DNA by a new class of ligands: two non-planar alkaloids through interaction in lateral grooves
Qian Li, Junfeng Xiang, Xudong Li, et al.
Histopathology
|
July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancers
Harsh Batra, Priya S C Bose, Yang Ding, et al.
Breast Cancer Research and Treatment
|
March 5, 2024
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis
Hongxia Sun, Eun Young Kang, Hui Chen, et al.
Clinical Breast Cancer
|
March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
Minhua Wang, Qingqing Ding, Jun Gu, et al.
Gut
|
January 9, 2026
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
Jing Liu, Xupeng Hou, Lin Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 9, 2025
Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer
Qiqi Ye, Timothy Law, Dianna Klippel, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Journal of Clinical Pathology
|
August 16, 2023
Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma
Qiqi Ye, Hui Chen, Cody Han, et al.
Molecular Cancer Research : MCR
|
September 15, 2007
Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status
Martín C Abba, Hongxia Sun, Kathleen A Hawkins, et al.
Molecular Oncology
|
March 8, 2014
Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue
Bilge Aktas, Hongxia Sun, Hui Yao, et al.
Virchows Archiv : an International Journal of Pathology
|
May 7, 2025
Upregulation of MMP9 expression in postradiation angiosarcoma of the breast: a possible predictive risk factor
Qingqing Ding, Phyu P Aung, Hongxia Sun, et al.
Biochimie
|
March 26, 2009
Stabilizing parallel G-quadruplex DNA by a new class of ligands: two non-planar alkaloids through interaction in lateral grooves
Qian Li, Junfeng Xiang, Xudong Li, et al.
Histopathology
|
July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancers
Harsh Batra, Priya S C Bose, Yang Ding, et al.
Breast Cancer Research and Treatment
|
March 5, 2024
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis
Hongxia Sun, Eun Young Kang, Hui Chen, et al.
Clinical Breast Cancer
|
March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
Minhua Wang, Qingqing Ding, Jun Gu, et al.
Gut
|
January 9, 2026
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
Jing Liu, Xupeng Hou, Lin Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 9, 2025
Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer
Qiqi Ye, Timothy Law, Dianna Klippel, et al.
Page
of 17